Mitsuya H - Search Results

1

Down-regulation of PU.1 by methylation of distal regulatory elements and the promoter is required for myeloma cell growth.

Tatetsu H, Ueno S, Hata H, Yamada Y, Takeya M, Mitsuya H, Tenen DG, Okuno Y. Tatetsu H, et al. Among authors: mitsuya h. Cancer Res. 2007 Jun 1;67(11):5328-36. doi: 10.1158/0008-5472.CAN-06-4265. Cancer Res. 2007. PMID: 17545613

2

Expression of Bcl-2 family of proteins in fresh myeloma cells.

Harada N, Hata H, Yoshida M, Soniki T, Nagasaki A, Kuribayashi N, Kimura T, Matsuzaki H, Mitsuya H. Harada N, et al. Among authors: mitsuya h. Leukemia. 1998 Nov;12(11):1817-20. doi: 10.1038/sj.leu.2401168. Leukemia. 1998. PMID: 9823959

3

Amplification and overexpression of the PRAD1/Cyclin D1 gene in a multiple myeloma cell line.

Sonoki T, Nakazawa N, Hata H, Taniwaki M, Nagasaki A, Seto M, Yoshida M, Kuribayashi N, Kimura T, Harada N, Mitsuya H, Matsuzaki H. Sonoki T, et al. Among authors: mitsuya h. Int J Hematol. 1998 Dec;68(4):459-61. Int J Hematol. 1998. PMID: 9885448 No abstract available.

4

Expression of PRAD1/cyclin D1 in plasma cell malignancy: incidence and prognostic aspects.

Sonoki T, Hata H, Kuribayashi N, Yoshida M, Harada N, Nagasaki A, Kimura T, Matsuno F, Mitsuya H, Matsuzaki H. Sonoki T, et al. Among authors: mitsuya h. Br J Haematol. 1999 Mar;104(3):614-7. doi: 10.1046/j.1365-2141.1999.01204.x. Br J Haematol. 1999. PMID: 10086803 Free article.

5

Detection of inducible nitric oxide synthase (iNOS) mRNA by RT-PCR in ATL patients and HTLV-I infected cell lines: clinical features and apoptosis by NOS inhibitor.

Sonoki T, Matsuzaki H, Nagasaki A, Hata H, Yoshida M, Matsuoka M, Kuribayashi N, Kimura T, Harada N, Takatsuki K, Mitsuya H, Mori M. Sonoki T, et al. Among authors: mitsuya h. Leukemia. 1999 May;13(5):713-8. doi: 10.1038/sj.leu.2401398. Leukemia. 1999. PMID: 10374875

6

A plasma cell leukemia patient showing bialleic 14q translocations: t(2;14) and t(11;14).

Sonoki T, Matsuzaki H, Satterwhite E, Nakazawa N, Hata H, Tucker PW, Taniwaki M, Kuribayashi N, Harada N, Matsuno F, Mitsuya H. Sonoki T, et al. Among authors: mitsuya h. Acta Haematol. 1999;101(4):197-201. doi: 10.1159/000040953. Acta Haematol. 1999. PMID: 10436301

7

Increasing methylation of the CDKN2A gene is associated with the progression of adult T-cell leukemia.

Nosaka K, Maeda M, Tamiya S, Sakai T, Mitsuya H, Matsuoka M. Nosaka K, et al. Among authors: mitsuya h. Cancer Res. 2000 Feb 15;60(4):1043-8. Cancer Res. 2000. PMID: 10706122

8

Down-regulation of CD98 in melphalan-resistant myeloma cells with reduced drug uptake.

Harada N, Nagasaki A, Hata H, Matsuzaki H, Matsuno F, Mitsuya H. Harada N, et al. Among authors: mitsuya h. Acta Haematol. 2000;103(3):144-51. doi: 10.1159/000041037. Acta Haematol. 2000. PMID: 10940652

9

Macrophage inflammatory protein-1 alpha is produced by human multiple myeloma (MM) cells and its expression correlates with bone lesions in patients with MM.

Uneda S, Hata H, Matsuno F, Harada N, Mitsuya Y, Kawano F, Mitsuya H. Uneda S, et al. Among authors: mitsuya h, mitsuya y. Br J Haematol. 2003 Jan;120(1):53-5. doi: 10.1046/j.1365-2141.2003.04040.x. Br J Haematol. 2003. PMID: 12492576 Free article.

10

A nitric oxide synthase inhibitor, N(G)-nitro-l-arginine-methyl-ester, exerts potent antiangiogenic effects on plasmacytoma in a newly established multiple myeloma severe combined immunodeficient mouse model.

Uneda S, Hata H, Matsuno F, Nagasaki A, Harada N, Mitsuya Y, Matsuzaki H, Mitsuya H. Uneda S, et al. Among authors: mitsuya h, mitsuya y. Br J Haematol. 2003 Feb;120(3):396-404. doi: 10.1046/j.1365-2141.2003.04078.x. Br J Haematol. 2003. PMID: 12580953 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

716 results

Search Page

Filters